Ovarian cancer vaccine shows promising results in human study

Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe an...

Posted: Apr 12, 2018 5:38 AM
Updated: Apr 12, 2018 5:38 AM

Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe and may lengthen the lives of ovarian cancer patients, a small clinical trial found.

The research, published Wednesday in the journal Science Translational Medicine, showed "significantly higher" overall survival at two years among patients who received the vaccine, compared with patients who did not.

85% of ovarian cancer patients relapse after treatment

"Personalized vaccines" inspire immune systems to fight cancer, a trial found

Ovarian cancer is a "silent killer" because often it goes unnoticed until it is diagnosed at a late stage. Treated with surgery followed by chemotherapy, most patients -- 85% -- relapse and ultimately develop resistance to the chemo. At this point, they run out of treatment options.

Still, scientists are hopeful based on the fact that a subset of patients shows an immune response to their cancer. Generally, these patients have better survival rates than those whose immune systems don't react in the same way.

A vaccine, then, might be able to trigger and boost the immune system and increase the survival rates of patients, said Dr. Lana Kandalaft, senior author of the new study and an adjunct assistant professor at the University of Pennsylvania Perelman School of Medicine.

Personalized medicine

Testing this hypothesis, Kandalaft and her colleagues created "personalized" vaccines for 25 patients diagnosed with advanced recurrent ovarian cancer. The women had recurrent advanced epithelial ovarian cancer, which has an average five-year survival rate of 17%, according to the American Cancer Society.

The scientists made each unique vaccine using a patient's tumor (stored and preserved before surgery) and dendritic cells from her blood.

Within the immune system, dendritic cells act as clever spies. Their mission is to identify foreign invaders lurking in the shadowy interfaces between our bodies and the environment: the lining of our airways, for example, and the surface of our intestines. Once they discover a virus or a dangerous toxin, dendritic cells will capture and display fragments of the invader on their surfaces and then travel deep into the lymph nodes, where the immune system's killer T cells reside.

Here, a simple introduction -- a knowing glance among friends -- takes place. The newly accessorized dendritic cells trigger the T cells to launch an attack in an attempt to destroy the invaders.

For the study, some patients received the personalized vaccine alone, and others received it in combination with either one or two chemo drugs (bevacizumab and cyclophosphamide).

"The patients who received the vaccine mounted an immune response against their own tumors," Kandalaft said in a statement. She described the immune response as "an increased number of T cells which were specific to the tumor and were able to kill tumors."

'Promising'

Each of the 25 patients received, on average, 16 vaccine shots over the course of the study and none experienced severe side effects from the vaccine.

Overall two-year survival was highest among responsive study patients who received the vaccine and two chemo drugs: Seventy-eight percent of vaccinated patients who also received the chemo drugs survived two years, compared with just 44% of patients who received the drugs but no vaccine.

Still, one vaccine-only patient remained in remission for five years after the study; prior to the study, her cancer had recurred twice after chemotherapy.

Dr. Otis Brawley, chief medical officer of the American Cancer Society, said the new study amounts to "good science" that "clearly justifies a larger clinical trial."

However, Brawley, who was not involved in the research, remains cautious of this "designer vaccine."

"Survival analysis is prone to some biases, which can mislead even the most experienced of clinical trialists," he said. The public "often wants to pass up better-proven conventional therapy for an unknown in immunotherapy."

Overall, Brawley is hopeful for immunotherapy as a treatment for ovarian cancer. "This methodology has been looked at in prostate cancer and may be useful in other diseases."

Going forward, Kandalaft and her colleagues will be pursuing larger studies of these vaccines. The results of the current study, designed to address safety and funded by National Institutes of Health, were "promising, albeit preliminary," she said.

Huntsville
Few Clouds
72° wxIcon
Hi: 73° Lo: 67°
Feels Like: 72°
Florence
Broken Clouds
71° wxIcon
Hi: 86° Lo: 70°
Feels Like: 71°
Fayetteville
Clear
72° wxIcon
Hi: 81° Lo: 68°
Feels Like: 72°
Decatur
Clear
71° wxIcon
Hi: 76° Lo: 68°
Feels Like: 71°
Scottsboro
Overcast
72° wxIcon
Hi: 80° Lo: 68°
Feels Like: 72°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Confirmed Cases: 49892

Reported Deaths: 1077
CountyConfirmedDeaths
Jefferson6433170
Mobile4753139
Montgomery4430112
Tuscaloosa263253
Madison21199
Marshall192611
Shelby164225
Lee157237
Morgan12695
Baldwin120711
Walker106131
Elmore102920
Dallas9969
Etowah95114
DeKalb9417
Franklin93216
Autauga67614
Russell6750
Chambers67427
Unassigned65328
Butler65129
Tallapoosa62869
Limestone6223
Houston5857
Cullman5716
Lauderdale5686
St. Clair5133
Colbert4956
Calhoun4905
Lowndes48122
Escambia4808
Pike4725
Coffee4244
Jackson4182
Covington41412
Barbour3942
Dale3911
Talladega3897
Bullock37710
Marengo35211
Hale34823
Chilton3232
Clarke3126
Wilcox3038
Blount2961
Winston2965
Sumter29113
Marion27514
Pickens2696
Randolph2589
Monroe2553
Perry2362
Conecuh2308
Bibb2211
Macon2159
Choctaw21212
Greene1959
Henry1533
Washington1418
Crenshaw1273
Lawrence1250
Cherokee1237
Geneva960
Lamar871
Clay852
Fayette821
Coosa651
Cleburne421
Out of AL00

Tennessee Coronavirus Cases

Confirmed Cases: 61006

Reported Deaths: 738
CountyConfirmedDeaths
Shelby13423223
Davidson13162143
Rutherford352539
Hamilton330538
Sumner189756
Williamson170816
Knox15919
Trousdale15085
Out of TN138410
Wilson114817
Putnam10117
Bradley9594
Robertson92413
Sevier9153
Unassigned9102
Montgomery7327
Lake6970
Tipton6967
Bledsoe6291
Bedford6239
Macon5977
Hamblen4724
Maury4543
Hardeman4114
Fayette3685
Madison3522
Blount3403
Loudon3322
Rhea3150
Dyer2913
McMinn27619
Cheatham2693
Washington2610
Dickson2580
Lawrence2326
Cumberland2134
Sullivan2104
Anderson1952
Jefferson1821
Lauderdale1804
Gibson1771
Monroe1556
Greene1512
Smith1502
Coffee1410
Cocke1360
Hardin1257
Warren1230
Obion1192
Haywood1183
Franklin1163
Marshall1152
Wayne1150
Carter1031
Giles1031
Hickman1030
McNairy1011
Marion944
Hawkins862
Lincoln860
DeKalb850
White853
Roane810
Overton721
Henderson710
Weakley701
Campbell691
Claiborne680
Grundy652
Chester630
Unicoi590
Grainger560
Polk550
Carroll521
Crockett523
Henry510
Cannon490
Sequatchie490
Jackson470
Johnson460
Humphreys392
Meigs380
Perry370
Morgan311
Decatur270
Fentress260
Scott260
Stewart260
Union250
Moore210
Clay200
Houston200
Benton151
Hancock110
Lewis110
Van Buren90
Pickett70

 

 

Community Events